Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Long term follow-up of the STOPAGO study

Blood blood.2024025707.

https://doi.org/10.1182/blood.2024025707

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Marion Larue, Guillaume Moulis, Manuela Rueter, Sylvain Audia, Louis Terriou, Jean-Francois Viallard, Brigitte Pan Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, Olivier Lambotte, Francois Lefrere, Stephane Cheze, Mikael Ebbo, Orianne Wagner-Ballon, Matthieu Mahevas, Bertrand Godeau, Marc Michel

Blood (2023) 142 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2023-181606

Published: 2023

Journal Articles

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Natasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, Jean-François Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikaël Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2023) 142 (12): 1099–1101.

https://doi.org/10.1182/blood.2023020311

Published: 2023

Includes: Supplemental data

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Blood (2023) 141 (1): 11–21.

https://doi.org/10.1182/blood.2022017277

Published: 2023

Includes: Supplemental data

Journal Articles

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Guillaume Moulis, Manuela Rueter, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau

Blood (2022) 140 (Supplement 1): 5557–5558.

https://doi.org/10.1182/blood-2022-157723

Published: 2022

Journal Articles

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Natacha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 52–54.

https://doi.org/10.1182/blood-2022-157715

Published: 2022

Journal Articles

An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database

Ségolène Fuentes, Basile Chrétien, Charles Dolladille, Joachim Alexandre, Anaël Dumont, Alexandre Nguyen, Hubert de Boysson, Stéphane Chèze, Gwénola Maigné, Achille Aouba, Samuel Deshayes

Blood (2022) 140 (8): 922–927.

https://doi.org/10.1182/blood.2022015936

Published: 2022

Includes: Supplemental data

Journal Articles

Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment

Blood (2021) 138 (Supplement 1): 17.

https://doi.org/10.1182/blood-2021-147450

Published: 2021

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia

Anais Roeser, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles, Hélène Labussière, Christelle Mausservey, Micheline Pha, Mathieu Puyade, Stephane Cheze, Nicolas Limal, Corinne Haioun, Marc Michel, Bertrand Godeau, Matthieu Mahevas

Blood (2021) 138 (Supplement 1): 3167.

https://doi.org/10.1182/blood-2021-153388

Published: 2021

Journal Articles

Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial

Blood (2021) 138 (Supplement 1): 2141.

https://doi.org/10.1182/blood-2021-148270

Published: 2021

Journal Articles

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

Marc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, Salam Alkindi, Stéphane Cheze, Waleed Ghanima, Tor Henrik Anderson Tvedt, Mikael Ebbo, Louis Terriou, James B. Bussel, Bertrand Godeau

Blood (2020) 136 (26): 3056–3061.

https://doi.org/10.1182/blood.2020007594

Published: 2020

Journal Articles

Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM)

Claire Jouzier, Amina Cherait, Pascale Cony-Makhoul, MD, Sylvain Thepot, MD, Thomas Cluzeau, MD PhD, Aspasia Stamatoulas Bastard, MD, Pierre Peterlin, MD, Agnes Guerci Bresler, MD, Sophie Dimicoli-Salazar, MD, Gian-Matteo Pica, MD, Stephane Cheze, MD, Clémence Santana, MD, Fatiha Chermat, Pierre Fenaux, MD PhD, Sophie Park, MD PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-138722

Published: 2020

Journal Articles

Risk Factors of Neonatal Immune Thrombocytopenia in Pregnant Women Previously Diagnosed with ITP: Results from a French Nationwide Prospective Study

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-140511

Published: 2020

Journal Articles

Outcome of Immune Thrombocytopenia in Pregnancy: A French Nationwide Prospective Multicenter Observational Case-Control Study

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-140329

Published: 2020

Journal Articles

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

Marc Michel, Marco Ruggeri, Tomás José González-López, MD, Stephane Cheze, MD, Waleed Ghanima, MD PhD, Tor Henrik Anderson Tvedt, Mikael Ebbo, MD PhD, James B. Bussel, MD, Bertrand Godeau, MD

Blood (2019) 134 (Supplement_1): 1081.

https://doi.org/10.1182/blood-2019-122595

Published: 2019

Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Blood (2018) 132 (Supplement 1): 467.

https://doi.org/10.1182/blood-2018-99-111756

Published: 2018

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Christian Rose, MD, Olivier Fitoussi, MD, Emmanuel Gyan, MD PhD, Maya Hacini, MD, Shanti Amé, MD, Bernadette Corront, MD, Odile Beyne-Rauzy, MD PhD, Didier Innocent Adiko, MD, Elena-Anca Loppinet, MD, Nadia Ali-Ammar, MD, Eric Wattel, MD PhD, Francois Dreyfus, MD, Stéphane Cheze, MD PhD

Blood (2016) 128 (22): 2008.

https://doi.org/10.1182/blood.V128.22.2008.2008

Published: 2016

NARROW

Long term follow-up of the STOPAGO study

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database

Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia

Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM)

Risk Factors of Neonatal Immune Thrombocytopenia in Pregnant Women Previously Diagnosed with ITP: Results from a French Nationwide Prospective Study

Outcome of Immune Thrombocytopenia in Pregnancy: A French Nationwide Prospective Multicenter Observational Case-Control Study

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only